Eco Animal Health gets approval for Aivlosin in Mexico

ECO Animal Health Group announced on Monday that its subsidiary, ECO Animal Health de México, has received a marketing authorisation from the Secretariat of Agriculture, Livestock, Rural Development, Fisheries and Food of the Government of Mexico for the use of Aivlosin 625 mg/g water soluble granules in chickens laying eggs for human consumption.

The AIM-traded firm said the approval, the first in Latin America following the European approval in June 2016, will allow ECO to start selling Aivlosin in Mexico for the medication of drinking water, for the treatment of infections caused by mycoplasma in poultry laying eggs for human consumption with a zero day drug withdrawal period for eggs.

Aivlosin is the company’s patented antimicrobial, with ECO saying it is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric diseases in poultry and pigs.

“This approval from the Mexican authorities is an important step in the development of Aivlosin for commercial layers with Mexico being the world’s fourth largest egg producing country,” said chairman Peter Lawrence.

“ECO has begun the process of submitting the Aivlosin regulatory files for the treatment of layers in numerous other key egg producing markets.

“It underlines ECO’s continued commitment to being a major force in the international market for veterinary pharmaceutical products.”